In PCOS patients the addition of low-dose spironolactone induces a more marked reduction of clinical and biochemical hyperandrogenism than metformin alone-Reference-Cited by-同舟云学术

In PCOS patients the addition of low-dose spironolactone induces a more marked reduction of clinical and biochemical hyperandrogenism than metformin alone

Published:2014-02 Issue:2 Volume:24 Page:132-139
ISSN:0939-4753
Container-title:Nutrition, Metabolism and Cardiovascular Diseases
language:en
Short-container-title:Nutrition, Metabolism and Cardiovascular Diseases

Author:

Mazza A.,Fruci B.,Guzzi P.,D'Orrico B.,Malaguarnera R.,Veltri P.,Fava A.,Belfiore A.

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine,Nutrition and Dietetics,Endocrinology, Diabetes and Metabolism,Medicine (miscellaneous)

Reference30 articles.

1. The prevalence of polycystic ovary syndrome in a community sample assessed under contrasting diagnostic criteria;March;Hum Reprod,2010

2. Evidence-based and potential benefits of metformin in the polycystic ovary syndrome: a comprehensive review;Palomba;Endocr Rev,2009

3. Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome;Fertil Steril,2004

4. Screening for 21-hydroxylase-deficient nonclassic adrenal hyperplasia among hyperandrogenic women: a prospective study;Azziz;Fertil Steril,1999

5. Hirsutism: implications, etiology, and management;Hatch;Am J Obstet Gynecol,1981

Cited by 38 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Gamma Oryzanol: A Natural Compound with Potential for Treating Polycystic Ovary Syndrome;Pharmacological Research - Modern Chinese Medicine;2024-09

2. Management of Hypertension in Patients With Polycystic Ovarian Syndrome: A Mini-Review;Cardiology in Review;2024-02-02

3. Reproductive Organ Therapies;Endocrinology;2023-12-15

4. Efficacy and safety of anti-androgens in the management of polycystic ovary syndrome: a systematic review and meta-analysis of randomised controlled trials;eClinicalMedicine;2023-09

5. Metformin combined with spironolactone vs. metformin alone in polycystic ovary syndrome: a meta-analysis;Frontiers in Endocrinology;2023-08-10